News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
65,494 Results
Type
Article (1551)
Company Profile (18)
Press Release (63925)
Section
Business (30335)
Career Advice (39)
Deals (4960)
Drug Delivery (2)
Drug Development (7450)
Employer Resources (9)
FDA (1198)
Job Trends (1735)
News (41733)
Policy (2114)
Tag
Academia (130)
Adcomms (1)
Allergies (5)
Alliances (2386)
ALS (3)
Alzheimer's disease (109)
Antibody-drug conjugate (ADC) (12)
Approvals (1212)
Artificial intelligence (15)
Autoimmune disease (2)
Automation (1)
Bankruptcy (13)
Best Places to Work (1674)
BIOSECURE Act (1)
Biosimilars (3)
Biotechnology (10)
Bladder cancer (7)
Brain cancer (2)
Breast cancer (39)
Cancer (281)
Cardiovascular disease (17)
Career advice (38)
Career pathing (1)
CAR-T (8)
Cell therapy (30)
Cervical cancer (4)
Clinical research (6594)
Collaboration (33)
Compensation (71)
COVID-19 (183)
CRISPR (2)
C-suite (14)
Cystic fibrosis (5)
Data (309)
Depression (3)
Diabetes (24)
Diagnostics (663)
Digital health (3)
Diversity, equity & inclusion (4)
Drug discovery (9)
Drug pricing (4)
Duchenne muscular dystrophy (6)
Earnings (27070)
Editorial (1)
Employer resources (8)
Events (7233)
Executive appointments (14)
FDA (1380)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (36)
Gene editing (4)
Generative AI (1)
Gene therapy (13)
GLP-1 (53)
Government (265)
Guidances (92)
Healthcare (2012)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (6)
Indications (6)
Infectious disease (195)
Inflammatory bowel disease (17)
Influenza (2)
Intellectual property (4)
Interviews (1)
IPO (3911)
IRA (2)
Job creations (164)
Job search strategy (37)
Kidney cancer (2)
Labor market (3)
Layoffs (20)
Legal (288)
Liver cancer (5)
Lung cancer (51)
Lymphoma (39)
Machine learning (1)
Management (3)
Manufacturing (15)
MASH (19)
Medical device (1627)
Medtech (1627)
Mergers & acquisitions (1129)
Metabolic disorders (76)
Multiple sclerosis (10)
NASH (3)
Neurodegenerative disease (6)
Neuropsychiatric disorders (1)
Neuroscience (144)
NextGen: Class of 2025 (490)
Non-profit (253)
Now hiring (2)
Obesity (34)
Opinion (5)
Ovarian cancer (5)
Pain (5)
Pancreatic cancer (11)
Parkinson's disease (10)
Partnered (2)
Patents (5)
Patient recruitment (3)
Peanut (2)
People (1898)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase I (1731)
Phase II (2771)
Phase III (2630)
Pipeline (511)
Policy (8)
Postmarket research (241)
Preclinical (440)
Press Release (1)
Prostate cancer (8)
Radiopharmaceuticals (27)
Rare diseases (21)
Real estate (223)
Recruiting (2)
Regulatory (1695)
Reports (4)
Research institute (247)
Resumes & cover letters (1)
RSV (3)
Schizophrenia (5)
Series A (4)
Service/supplier (1)
Sickle cell disease (4)
Special edition (2)
Spinal muscular atrophy (14)
Sponsored (3)
Startups (120)
Stomach cancer (1)
Tariffs (5)
The Weekly (1)
Vaccines (42)
Weight loss (19)
Women's health (1)
Date
Last 7 days (232)
Last 30 days (464)
Last 365 days (4301)
2025 (1591)
2024 (4778)
2023 (5429)
2022 (6340)
2021 (7343)
2020 (6563)
2019 (4537)
2018 (3551)
2017 (3035)
2016 (2102)
2015 (3112)
2014 (2088)
2013 (1410)
2012 (1618)
2011 (1780)
2010 (1634)
Location
Africa (37)
Alabama (16)
Arizona (12)
Asia (4331)
Australia (304)
California (980)
Canada (241)
China (58)
Colorado (31)
Connecticut (36)
Delaware (33)
Europe (8558)
Florida (127)
Georgia (33)
Idaho (2)
Illinois (50)
India (3)
Indiana (43)
Iowa (3)
Japan (17)
Kansas (7)
Kentucky (4)
Louisiana (4)
Maine (11)
Maryland (123)
Massachusetts (624)
Michigan (21)
Minnesota (62)
Missouri (2)
Montana (4)
Nebraska (2)
Nevada (6)
New Hampshire (10)
New Jersey (278)
New Mexico (1)
New York (206)
North Carolina (122)
North Dakota (1)
Northern California (485)
Ohio (28)
Oregon (11)
Pennsylvania (199)
Puerto Rico (1)
Rhode Island (1)
South America (76)
Southern California (379)
Tennessee (11)
Texas (93)
United States (3244)
Utah (34)
Virginia (7)
Washington D.C. (5)
Washington State (70)
Wisconsin (4)
65,494 Results for "62".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Diabetes Care Market Size to worth to Reach USD 62.73 Billion by 2032, Coherent Market Insights
May 8, 2025
·
1 min read
Press Releases
Telix Reports US$186M Q1 Revenue, Up 62% YOY
April 22, 2025
·
14 min read
Press Releases
Dermata Therapeutics Announces Exercise of Warrants for $6.2 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
March 28, 2025
·
6 min read
Press Releases
Light Horse Therapeutics Debuts With $62 Million Series A Financing
January 9, 2025
·
5 min read
Press Releases
Aptevo Therapeutics Announces Exercise of Warrants for $6.2 Million Gross Proceeds
December 13, 2024
·
6 min read
Press Releases
NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million
January 10, 2025
·
6 min read
Press Releases
Viral Vector Production (Research-use) Market Size to Hit USD 7.62 Bn by 2034
December 17, 2024
·
1 min read
Drug Development
Sparrow Pharmaceuticals to Present on HSD-1 Inhibitor Clofutriben (SPI-62) for Polymyalgia Rheumatica at the European Congress of Rheumatology 2024
Sparrow Pharmaceuticals will present interim results from a Phase 2 clinical trial of its novel HSD-1 inhibitor, clofutriben (SPI-62), administered in combination with prednisolone to patients with polymyalgia rheumatica, at the European Congress of Rheumatology (EULAR) 2024 congress in Vienna, Austria during a highlighted session, “The 75th Anniversary of Glucocorticoids - what have we learnt?”
June 6, 2024
·
1 min read
Press Releases
Global Single-cell Omics Market worth $4.62 Billion by 2030, Coherent Market Insights
November 20, 2024
·
1 min read
Business
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
Johnson & Johnson announced that its Board of Directors has declared a 4.2% increase in the quarterly dividend, from $1.19 per share to $1.24 per share, marking the 62nd year of consecutive increases.
April 16, 2024
·
1 min read
1 of 6,550
Next
